About Maxwell biosystems
MaxWell Biosystems AG is a leading provider of innovative solutions that are designed to advance basic neuroscience research and accelerate preclinical drug discovery. The company has been at the forefront of developing cutting-edge technologies that enable researchers to better understand the complex workings of the brain and nervous system, with a particular focus on developing new treatments for neurological disorders.
At MaxWell Biosystems, we believe that understanding the brain is key to unlocking new treatments for a wide range of neurological conditions. Our team of experts is dedicated to developing state-of-the-art tools and technologies that enable researchers to study neural circuits in unprecedented detail, allowing them to gain insights into how these circuits function and how they can be manipulated in order to develop new therapies.
One of our flagship products is our multiwell microelectrode array (MEA) platform, which enables high-throughput electrophysiology experiments on live cells. This technology allows researchers to simultaneously record electrical activity from multiple neurons or other cells in real-time, providing valuable insights into how these cells communicate with one another and respond to different stimuli.
In addition to our MEA platform, we also offer a range of other cutting-edge tools and technologies for studying neural circuits. These include optogenetics systems for controlling neuronal activity with light, as well as advanced imaging systems for visualizing neural activity in real-time.
At MaxWell Biosystems, we are committed not only to advancing basic neuroscience research but also accelerating preclinical drug discovery. Our technologies have already been used by leading pharmaceutical companies around the world in their efforts to develop new treatments for neurological disorders such as Alzheimer's disease, Parkinson's disease, epilepsy, and more.
Our team consists of some of the brightest minds in neuroscience research today. We are passionate about what we do and are constantly pushing ourselves forward through innovation and collaboration with leading academic institutions around the world.
If you're looking for innovative solutions that can help you advance your own neuroscience research or accelerate your preclinical drug discovery efforts, look no further than MaxWell Biosystems AG. With our cutting-edge technologies and world-class team of experts, we are committed to helping you achieve your goals and make a real difference in the fight against neurological disorders.